The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Metformin—mode of action and clinical implications for diabetes and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
Obesity and Cardiovascular Disease
Lavie, C. J., Milani, R. V., & Ventura, H. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.068 · Cited by 2,326
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Foye's Principles of Medicinal Chemistry
Foye, W. O., Lemke, T., & Williams, D. A. (2012) · Cited by 1,407
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Jeon, S.-M., Chandel, N. S., & Hay, N. (2012) · Nature · doi:10.1038/nature11066 · Cited by 1,132
Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115
CREB and the CRTC co-activators: sensors for hormonal and metabolic signals
Altarejos, J. Y., & Montminy, M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3072 · Cited by 1,040
Fryer, L. G. D., Parbu-Patel, A., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,029
Buzzai, M., Jones, R. G., Amaravadi, R. K., Lum, J. J., DeBerardinis, R. J., Zhao, F., Viollet, B., & Thompson, C. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4447 · Cited by 923
Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1
Bar-Peled, L., Schweitzer, L. D., Zoncu, R., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.07.032 · Cited by 918
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B. J., Viollet, B., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.001 · Cited by 911
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner
Kalender, A., Selvaraj, A., Kim, S. Y., Gulati, P., Brûlé, S., Viollet, B., Kemp, B. E., Bardeesy, N., Dennis, P., Schlager, J. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.014 · Cited by 889
Liang, J., Shao, S. H., Xu, Z.-X., Hennessy, B., Ding, Z., Larrea, M., Kondo, S., Dumont, D. J., Gutterman, J. U., Walker, C. L., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1537 · Cited by 866
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Miller, R. A., Chu, Q., Xie, J., Foretz, M., Viollet, B., & Birnbaum, M. J. (2013) · Nature · doi:10.1038/nature11808 · Cited by 833
Traditional Plant Medicines as Treatments for Diabetes
Bailey, C. J., & Day, C. (1989) · Diabetes Care · doi:10.2337/diacare.12.8.553 · Cited by 832
UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals
Andrews, Z. B., Liu, Z.-W., Walllingford, N., Erion, D. M., Borok, E., Friedman, J. M., Tschöp, M. H., Shanabrough, M., Cline, G., Shulman, G. I., et al. (2008) · Nature · doi:10.1038/nature07181 · Cited by 710
Hawley, S. A., Gadalla, A. E., Olsen, G. S., & Hardie, D. G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2420 · Cited by 696
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
Thomas, G. V., Tran, C., Mellinghoff, I. K., Welsbie, D. S., Chan, E., Fueger, B., Czernin, J., & Sawyers, C. L. (2006) · Nature Medicine · doi:10.1038/nm1337 · Cited by 604
Gelling, R. W., Du, X. Q., Dichmann, D. S., Rømer, J., Huang, H., Cui, L., Obici, S., Tang, B., Holst, J. J., Fledelius, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237106100 · Cited by 563
Metformin and the Risk of Cancer
Suissa, S., & Azoulay, L. (2012) · Diabetes Care · doi:10.2337/dc12-0788 · Cited by 531
Improved Endothelial Function With Metformin in Type 2 Diabetes Mellitus
Mather, K. J., Verma, S., & Anderson, T. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01129-9 · Cited by 513
Goldstein, B. J., Feinglos, M. N., Lunceford, J. K., Johnson, J., Williams-Herman, D. E., & for the Sitagliptin 036 Study Group (2007) · Diabetes Care · doi:10.2337/dc07-0627 · Cited by 509
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Pollak, M. N. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0263 · Cited by 507
Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells
Isoda, K., Young, J. L., Zirlik, A., MacFarlane, L. A., Tsuboi, N., Gerdes, N., Schönbeck, U., & Libby, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201938.78044.75 · Cited by 499
Zaugg, K., Yao, Y., Reilly, P. T., Kannan, K., Kiarash, R., Mason, J., Huang, P., Sawyer, S. K., Fuerth, B., Faubert, B., et al. (2011) · Genes & Development · doi:10.1101/gad.1987211 · Cited by 490
Hattori, Y., Suzuki, K., Hattori, S., & Kasai, K. (2006) · Hypertension · doi:10.1161/01.hyp.0000221429.94591.72 · Cited by 487
He, L., Sabet, A., Djedjos, S., Miller, R., Sun, X., Hussain, M. A., Radovick, S., & Wondisford, F. E. (2009) · Cell · doi:10.1016/j.cell.2009.03.016 · Cited by 481
Kola, B., Hubina, E., Tucci, S. A., Kirkham, T. C., Garcia, E. A., Mitchell, S. E., Williams, L. M., Hawley, S. A., Hardie, D. G., Grossman, A. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500175200 · Cited by 472
Self-citationRegulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival
Efeyan, A., Zoncu, R., Chang, S., Gumper, I., Snitkin, H., Wolfson, R. L., Kirak, O., Sabatini, D. D., & Sabatini, D. M. (2013) · Nature · doi:10.1038/nature11745 · Cited by 455
Zang, M., Zuccollo, A., Hou, X., Nagata, D., Walsh, K., Herscovitz, H., Brecher, P., Ruderman, N. B., & Cohen, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408149200 · Cited by 453
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3471 · Cited by 450
Hirsch, H. A., Iliopoulos, D., & Struhl, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221055110 · Cited by 440
Hunger States Switch a Flip-Flop Memory Circuit via a Synaptic AMPK-Dependent Positive Feedback Loop
Yang, Y., Atasoy, D., Su, H. H., & Sternson, S. M. (2011) · Cell · doi:10.1016/j.cell.2011.07.039 · Cited by 438
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
The GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group, & The Wellcome Trust Case Control Consortium 2 (2011) · Nature Genetics · doi:10.1038/ng.735 · Cited by 432
Kennedy, L. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79145-5 · Cited by 427
Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes
Quesada, I., Tudurí, E., Ripoll, C., & Nadal, Á. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0290 · Cited by 412
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Huang, X., Wullschleger, S., Shpiro, N., McGuire, V. A., Sakamoto, K., Woods, Y. L., Mcburnie, W., Fleming, S., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20080557 · Cited by 396
Lochhead, P. A., Salt, I. P., Walker, K. S., Hardie, D. G., & Sutherland, C. (2000) · Diabetes · doi:10.2337/diabetes.49.6.896 · Cited by 390
Foretz, M., Ancellin, N., Andreelli, F., Saintillan, Y., Grondin, P., Kahn, A., Thorens, B., Vaulont, S., & Viollet, B. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1331 · Cited by 388
Nies, A. T., Koepsell, H., Damme, K., & Schwab, M. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_3 · Cited by 375
Metformin reduces endogenous reactive oxygen species and associated DNA damage
Algire, C., Moiseeva, O., Deschênes-Simard, X., Amrein, L., Petruccelli, L., Birman, E., Viollet, B., Ferbeyre, G., & Pollak, M. N. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0536 · Cited by 372
Targeting glucose metabolism for cancer therapy
Hamanaka, R. B., & Chandel, N. S. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120162 · Cited by 369
Nath, N., Khan, M., Paintlia, M. K., Hoda, M. N., & Giri, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803563 · Cited by 354
Nagi, D. K., & Yudkin, J. S. (1993) · Diabetes Care · doi:10.2337/diacare.16.4.621 · Cited by 353
Tzvetkov, M. V., Vormfelde, S. V., Balen, D., Meineke, I., Schmidt, T., Sehrt, D., Sabolić, I., Koepsell, H., & Brockmöller, J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.92 · Cited by 349
Hermann, L. S., Scherstén, B., Bitzén, P.-O., Kjellström, T., Lindgärde, F., & Melander, A. (1994) · Diabetes Care · doi:10.2337/diacare.17.10.1100 · Cited by 344
Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
Hosono, K., Endo, H., Takahashi, H., Sugiyama, M., Sakai, E., Uchiyama, T., Suzuki, K., Iida, H., Sakamoto, Y., Yoneda, K., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0186 · Cited by 311
LKB1 and AMPK and the cancer-metabolism link - ten years after
Hardie, D. G., & Alessi, D. R. (2013) · BMC Biology · doi:10.1186/1741-7007-11-36 · Cited by 301
Cardiovascular Outcomes in Trials of Oral Diabetes Medications: A Systematic Review
Selvin, E., Bolen, S., Yeh, H.-C., Wiley, C., Wilson, L. M., Marinopoulos, S. S., Feldman, L., Vassy, J., Wilson, R., Bass, E. B., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.19.2070 · Cited by 300
Maida, A., Lamont, B. J., Cao, X., & Drucker, D. J. (2011) · Diabetologia · doi:10.1007/s00125-010-1937-z · Cited by 294
Hadad, S., Iwamoto, T., Jordan, L., Purdie, C., Bray, S., Baker, L., Jellema, G., Deharo, S., Hardie, D. G., Pusztai, L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1612-1 · Cited by 293
Becker, M. L., Visser, L. E., van Schaik, R. H. N., Hofman, A., Uitterlinden, A. G., & Stricker, B. H. C. (2009) · Diabetes · doi:10.2337/db08-1028 · Cited by 290
Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
Song, C. W., Lee, H., Dings, R. P. M., Williams, B., Powers, J., Santos, T. D., Choi, B.-H., & Park, H. J. (2012) · Scientific Reports · doi:10.1038/srep00362 · Cited by 280
Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer
Clem, B. F., O'Neal, J., Tapolsky, G., Clem, A. L., Imbert-Fernandez, Y., Kerr, D. A., Klarer, A. C., Redman, R., Miller, D. M., Trent, J. O., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0097 · Cited by 276
Burgess, S. C., He, T., Yan, Z., Lindner, J., Sherry, A. D., Malloy, C. R., Browning, J. D., & Magnuson, M. A. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.004 · Cited by 276
Ros, S., & Schulze, A. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-8 · Cited by 269
Boussageon, R., Supper, I., Bejan-Angoulvant, T., Kellou, N., Cucherat, M., Boissel, J.-P., Kassai, B., Moreau, A., Gueyffier, F., & Cornu, C. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001204 · Cited by 266
Lactic acidosis in biguanide-treated diabetics: A review of 330 cases
Luft, D., Schm�lling, R. M., & Eggstein, M. (1978) · Diabetologia · doi:10.1007/bf01263444 · Cited by 262
Zhou, M., Xia, L., & Wang, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015495 · Cited by 251
Pierotti, M. A., Berrino, F., Gariboldi, M., Melani, C., Mogavero, A., Negri, T., Pasanisi, P., & Pilotti, S. (2013) · Oncogene · doi:10.1038/onc.2012.181 · Cited by 250
Meta-analysis: metformin treatment in persons at risk for diabetes mellitus
Salpeter, S. R., Buckley, N. S., Kahn, J. A., & Salpeter, E. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.09.016 · Cited by 248
Preservation of β-Cell Function: The Key to Diabetes Prevention
DeFronzo, R. A., & Abdul-Ghani, M. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0246 · Cited by 247
Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
Blandino, G., Valerio, M., Cioce, M., Mori, F., Casadei, L., Pulito, C., Sacconi, A., Biagioni, F., Cortese, G., Galanti, S., et al. (2012) · Nature Communications · doi:10.1038/ncomms1859 · Cited by 242
Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
Ouyang, J., Parakhia, R. A., & Ochs, R. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121806 · Cited by 242
The role of dysregulated glucagon secretion in type 2 diabetes
D'Alessio, D. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01449.x · Cited by 238
Gunton, J. E., Delhanty, P. J. D., Takahashi, S.-I., & Baxter, R. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021394 · Cited by 234
Algire, C., Amrein, L., Zakikhani, M., Panasci, L., & Pollak, M. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-09-0252 · Cited by 234
Lactic Acidosis Rates in Type 2 Diabetes
Brown, J. B., Pedula, K., Barzilay, J., Herson, M. K., & Latare, P. (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1659 · Cited by 223
DE JAGER, J., KOOY, A., LEHERT, P., BETS, D., WULFFELÉ, M. G., TEERLINK, T., SCHEFFER, P. G., SCHALKWIJK, C. G., DONKER, A. J. M., & STEHOUWER, C. D. A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01420.x · Cited by 220
Inhibition by AICA Riboside of Gluconeogenesis in Isolated Rat Hepatocytes
Vincent, M. F., Marangos, P. J., Gruber, H. E., & van den Berghe, G. (1991) · Diabetes · doi:10.2337/diab.40.10.1259 · Cited by 217
Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Zhou, W., Simpson, P. J., McFadden, J. M., Townsend, C. A., Medghalchi, S. M., Vadlamudi, A., Pinn, M. L., Ronnett, G. V., & Kuhajda, F. P. (2003) · PubMed · Cited by 216
Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes
Wang, Y., Li, G., Goode, J., Paz, J. C., Ouyang, K., Screaton, R., Fischer, W. H., Chen, J., Tabas, I., & Montminy, M. (2012) · Nature · doi:10.1038/nature10988 · Cited by 210
Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase
Park, C. S., Bang, B.-R., Kwon, H.-S., Moon, K.-A., Kim, T.-B., Lee, K.-Y., Moon, H.-B., & Cho, Y. S. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.025 · Cited by 208
He, X., Esteva, F. J., Ensor, J., Hortobagyi, G. N., Lee, M.-H., & Yeung, S.-C. J. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr534 · Cited by 207
Chen, L., Pawlikowski, B., Schlessinger, A., More, S. S., Stryke, D., Johns, S. J., Portman, M. A., Chen, E., Ferrin, T. E., Sali, A., et al. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833fe789 · Cited by 207
Giugliano, D., De Rosa, N., Di Maro, G., Marfella, R., Acampora, R., Buoninconti, R., & D'Onofrio, F. (1993) · Diabetes Care · doi:10.2337/diacare.16.10.1387 · Cited by 206
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
Lee, J. H., Kim, T. I., Jeon, S. M., Hong, S. P., Cheon, J. H., & Kim, W. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.26421 · Cited by 204
Mechanism of metformin action in non-insulin-dependent diabetes
Jackson, R. A., Hawa, M. I., Jaspan, J. B., Sim, B. M., DiSilvio, L., Featherbe, D., & Kurtz, A. B. (1987) · Diabetes · doi:10.2337/diab.36.5.632 · Cited by 202
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5
Caton, P. W., Nayuni, N. K., Kieswich, J., Khan, N. Q., Yaqoob, M. M., & Corder, R. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0345 · Cited by 198
Chen, G., Xu, S., Renko, K., & Derwahl, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1754 · Cited by 196
Chu, N. V., Kong, A. P. S., Kim, D. D., Armstrong, D., Baxi, S., Deutsch, R., Caulfield, M., Mudaliar, S. R., Reitz, R., Henry, R. R., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.542 · Cited by 196
Glueck, C. J., Fontaine, R. N., Wang, P., Subbiah, M. T. R., Weber, K., Illig, E., Streicher, P., Sieve-Smith, L., Tracy, T. M., Lang, J. E., et al. (2001) · Metabolism · doi:10.1053/meta.2001.24192 · Cited by 188
Potential applications for biguanides in oncology
Pollak, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67232 · Cited by 188
Preiss, D., Lloyd, S. M., Ford, I., McMurray, J. J., Holman, R. R., Welsh, P., Fisher, M., Packard, C. J., & Sattar, N. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70152-9 · Cited by 187
Metformin suppresses intestinal polyp growth in Apc Min/+ mice
Tomimoto, A., Endo, H., Sugiyama, M., Fujisawa, T., Hosono, K., Takahashi, H., Nakajima, N., Nagashima, Y., Wada, K., Nakagama, H., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00933.x · Cited by 185
Algire, C., Amrein, L., Bazile, M., David, S., Zakikhani, M., & Pollak, M. (2011) · Oncogene · doi:10.1038/onc.2010.483 · Cited by 181
Samuel, V. T., Beddow, S. A., Iwasaki, T., Zhang, X.-M., Chu, X., Still, C. D., Gerhard, G. S., & Shulman, G. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812547106 · Cited by 176
Metformin: a review of its pharmacological properties and therapeutic use.
Ls, H. (1979) · PubMed · Cited by 173
Christ‐Crain, M., Kola, B., Lolli, F., Fekete, C., Seboek, D., Wittmann, G., Feltrin, D., Igreja, S. C., Ajodha, S., Harvey‐White, J., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-094144 · Cited by 170
Self-citationPatanè, G., Piro, S., Rabuazzo, A. M., Anello, M., Vigneri, R., & Purrello, F. (2000) · Diabetes · doi:10.2337/diabetes.49.5.735 · Cited by 169
Biguanide-Associated Lactic Acidosis: Case Report and Review of the Literature
Gan, S. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.11.2333 · Cited by 166
Gokcel, A., Gumurdulu, Y., Karakose, H., Melek Ertorer, E., Tanaci, N., Bascil Tutuncu, N., & Guvener, N. (2002) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00181.x · Cited by 164
Lee, J.-M., Seo, W.-Y., Song, K.-H., Chanda, D., Kim, Y. D., Kim, D.-K., Lee, M.-W., Ryu, D., Kim, Y.-H., Noh, J.-R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134890 · Cited by 162
An energetic tale of AMPK-independent effects of metformin
Miller, R. A., & Birnbaum, M. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43661 · Cited by 162
Goodarzi, M. O., & Bryer‐Ash, M. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00448.x · Cited by 162
Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
Emami Riedmaier, A., Fisel, P., Nies, A. T., Schaeffeler, E., & Schwab, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.11.005 · Cited by 161
Kita, Y., Takamura, T., Misu, H., Ota, T., Kurita, S., Takeshita, Y., Uno, M., Nagata, N., Kato, K., Ando, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043056 · Cited by 159
Collier, C., Bruce, C. R., Smith, A. C., Lopaschuk, G. D., & Dyck, D. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00272.2005 · Cited by 159
Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes
Lindsay, J. R., Duffy, N. A., McKillop, A. M., Ardill, J., O'Harte, F. P. M., Flatt, P. R., & Bell, P. M. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01461.x · Cited by 158
Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis
Kang, K. Y., Kim, Y., Yi, H., Kim, J., Jung, H., Kim, I. J., Cho, J., Park, S., Kim, H., & Ju, J. H. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.03.020 · Cited by 147
Effect of Biguanides on Intestinal Absorption of Glucose
Czyżyk, A., Tawecki, J., Sadowski, J., et al. (1968) · Diabetes · doi:10.2337/diab.17.8.492 · Cited by 147
Enhanced secretion of glucagon-like peptide 1 by biguanide compounds
Yasuda, N., Inoue, T., Nagakura, T., Yamazaki, K., Kira, K., Saeki, T., & Tanaka, I. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02565-2 · Cited by 137
Adiponectin, obesity, and cardiovascular disease
Faßhauer, M., Paschke, R., & Stümvoll, M. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.016 · Cited by 136
Morris, J. C., Chiche, J., Grellier, C., Lopez, M., Bornaghi, L. F., Maresca, A., Supuran, C. T., Pouysségur, J., & Poulsen, S. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200892s · Cited by 128
Biguanide-Associated Lactic Acidosis
Gan, S. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400230129023 · Cited by 126
Chau-Van, C., Gamba, M., Salvi, R., Gaillard, R. C., & Pralong, F. P. (2006) · Endocrinology · doi:10.1210/en.2006-1237 · Cited by 121
Lv, W., Wen, J., Li, L., Sun, R., Wang, J., Xian, Y., Cao, C., Wang, Y., & Gao, Y. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.028 · Cited by 118
Cellular Responses to the Metal-Binding Properties of Metformin
Logie, L., Harthill, J. E., Patel, K., Bacon, S., Hamilton, D. L., Macrae, K., McDougall, G. J., Wang, H., Xue, L., Jiang, H., et al. (2012) · Diabetes · doi:10.2337/db11-0961 · Cited by 116
Janjetović, K., Vucicevic, L. M., Misirkic-Marjanovic, M., Vilimanovich, U., Tovilović-Kovačević, G., Zogovic, N. S., Nikolić, Z., Jovanović, S., Bumbasirevic, V. Z., Trajković, V., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.11.005 · Cited by 115
Fischer, Y., Thomas, J., Rosen, P., & Kammermeier, H. (1995) · Endocrinology · doi:10.1210/endo.136.2.7835271 · Cited by 114
Seo, S., Ju, S., Chung, H., Lee, D., & Seungjoon, P. A. R. K. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-091 · Cited by 113
Cation and structural requirements for P site-mediated inhibition of adenylate cyclase.
Johnson, R. A., Yeung, S. M., Stübner, D., Bushfield, M., & Shoshani, I. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11415-6 · Cited by 113
Association Between Metformin Therapy and Mortality After Breast Cancer
Lega, I. C., Austin, P. C., Gruneir, A., Goodwin, P. J., Rochon, P. A., & Lipscombe, L. L. (2013) · Diabetes Care · doi:10.2337/dc12-2535 · Cited by 112
Arai, M., Uchiba, M., Komura, H., Mizuochi, Y., Harada, N., & Okajima, K. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164970 · Cited by 108
Phenformin as prophylaxis and therapy in breast cancer xenografts
Appleyard, M. V. C. L., Murray, K. E., Coates, P. J., Wullschleger, S., Bray, S. E., Kernohan, N. M., Fleming, S., Alessi, D. R., & Thompson, A. M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.56 · Cited by 108
Hemmingsen, B., Lundby‐Christensen, L., Wetterslev, J., Vaag, A. A., Gluud, C. N., Lund, S. S., & Almdal, T. (2012) · BMJ · doi:10.1136/bmj.e1771 · Cited by 108
The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
Ye, Y., Perez-Polo, J. R., Aguilar, D. A., & Birnbaum, Y. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0216-6 · Cited by 101
Détaille, D., Guigas, B., Leverve, X. M., Wiernsperger, N. F., & Devos, P. E. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00858-4 · Cited by 100
McIntyre, D. H., Paterson, C. A., Ma, A., Ravenscroft, P. J., Bird, D., & Cameron, D. P. (1991) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1991.tb01375.x · Cited by 98
Relevance of the OCT1 transporter to the antineoplastic effect of biguanides
Segal, E., Yasmeen, A., Beauchamp, M.-C., Rosenblatt, J., Pollak, M., & Gotlieb, W. H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.134 · Cited by 97
Biochemical diagnosis of pralactinoma.
Cowden, E., Jg, R., Ja, T., et al. (1979) · PubMed · Cited by 97
New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser
Cho, Y. M., & Kieffer, T. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1986-3 · Cited by 91
Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes
Matsumoto, K., Sera, Y., Abe, Y., Tominaga, T., Yeki, Y., & Miyake, S. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.11.007 · Cited by 90
Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments
Lenhard, J. M., Croom, D. K., & Minnick, D. T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.021 · Cited by 90
Liu, L., Zhang, C., Hu, Y., & Peng, B. (2012) · Journal of Endodontics · doi:10.1016/j.joen.2012.03.010 · Cited by 90
Ning, J., & Clemmons, D. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0474 · Cited by 90
Mechanism of Action of Metformin: Insulin Receptor and Postreceptor Effects in Vitro and in Vivo*
Fantus, I. G., & Brosseau, R. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-4-898 · Cited by 88
Fulgencio, J.-P., Kohl, C., Girard, J. R., & Pégorier, J. P. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00679-7 · Cited by 87
Dickens, F. (1940) · Nature · doi:10.1038/145512b0 · Cited by 85
Cicero, A. F. G., Tartagni, E., & Ertek, S. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.31622 · Cited by 84
Metformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated DNA damage-like response
Vazquez-Martin, A., Oliveras-Ferraros, C., Cufí, S., Martin-Castillo, B., & Menendez, J. A. (2011) · Cell Cycle · doi:10.4161/cc.10.9.15423 · Cited by 81
Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression
Dong, L., Zhou, Q., Zhang, Z., Zhu, Y., Duan, T., & Feng, Y. (2012) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2011.01839.x · Cited by 79
Donnelly, L. A., Morris, A. D., & Pearson, E. R. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00973.x · Cited by 78
Nakamichi, N., Shima, H., Asano, S., Ishimoto, T., Sugiura, T., Matsubara, K., Kusuhara, H., Sugiyama, Y., Sai, Y., Miyamoto, K., et al. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23595 · Cited by 77
Antidiabetic Drug Metformin Suppresses Endotoxin-Induced Uveitis in Rats
Kalariya, N. M., Shoeb, M., Ansari, N. H., Sk, S., & Ramana, K. V. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9432 · Cited by 76
Bhat, V. K., Kerr, B. D., Flatt, P. R., & Gault, V. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.03.009 · Cited by 75
Hermida, N., Markl, A., Hamelet, J., Assche, T. V., Vanderper, A., Herijgers, P., van Bilsen, M., Hilfiker‐Kleiner, D., Noppe, G., Beauloye, C., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt070 · Cited by 74
Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors
Cubeddu, L. X., Bönisch, H., Göthert, M., Molderings, G. J., Racké, K., Ramadori, G. P., Miller, K. J., & Schwörer, H. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900152 · Cited by 67
Stith, B. J., Goalstone, M. L., Espinoza, R., Mossel, C., Roberts, D., & Wiernsperger, N. F. (1996) · Endocrinology · doi:10.1210/endo.137.7.8770923 · Cited by 66
A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes
Sogame, Y., Kitamura, A., Yabuki, M., & Komuro, S. (2009) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.684 · Cited by 65
Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice
Yuan, H., Li, L., Zheng, W., Wan, J., Ge, P., Li, H., & Zhang, L. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.01.015 · Cited by 59
Prager, R., & Schernthaner, G. (1983) · Diabetes · doi:10.2337/diab.32.12.1083 · Cited by 58
Gómez-Díaz, R. A., Talavera, J. O., Canché-Pool, E. B., Ortiz-Navarrete, V. F., Solórzano‐Santos, F., Mondragón-González, R., Valladares‐Salgado, A., Cruz, M., Aguilar-Salinas, C. A., & Wacher, N. H. (2012) · Metabolism · doi:10.1016/j.metabol.2012.02.003 · Cited by 53
Stevanović, D., Janjetović, K., Misirkic-Marjanovic, M., Vucicevic, L. M., Šumarac-Dumanović, M., Micić, D., Starcevic, V. P., & Trajković, V. (2012) · Neuroendocrinology · doi:10.1159/000333963 · Cited by 53
Action of metformin on erythrocyte membrane fluidity in vitro and in vivo
Muller, S., Denet, S., Candiloros, H., Barrois, R., Wiernsperger, N. F., Donner, M., & Drouin, P. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01287-9 · Cited by 52
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
Dandapani, M., & Hardie, D. G. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120351 · Cited by 52
FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE
Chakrabarti, R., Hocking, E., & Fearnley, G. R. (1965) · The Lancet · doi:10.1016/s0140-6736(65)92383-4 · Cited by 52
Kajbaf, F., Arnouts, P., Broe, M. E. D., & Lalau, J. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3501 · Cited by 51
Metformin as an energy restriction mimetic agent for breast cancer prevention
Thompson, H. J., Zhu, Z., Thompson, M., Jiang, W., & McGinley, J. N. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.83043 · Cited by 51
Andrews, M., Néstor Soto, I., & Arredondo, M. (2012) · Revista médica de Chile · doi:10.4067/s0034-98872012001100001 · Cited by 47
Shitara, Y., Nakamichi, N., Norioka, M., Shima, H., Kato, Y., & Horie, T. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs330 · Cited by 47
Control of Glycolytic Flux by AMP-Activated Protein Kinase in Tumor Cells Adapted to Low pH
Mendoza, E. E., Pocceschi, M. G., Kong, X., Leeper, D. B., Caro, J., Limesand, K. H., & Burd, R. (2012) · Translational Oncology · doi:10.1593/tlo.11319 · Cited by 43
Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes
Otto, M., Breinholt, J., & Westergaard, N. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00263.x · Cited by 39
Niraula, S., Pond, G. R., de Wit, R., Eisenberger, M. A., Tannock, I. F., & Joshua, A. M. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.267 · Cited by 38
Vázquez‐Martín, A., Oliveras‐Ferraros, C., Barco, S. D., Martı́n-Castillo, B., & Menéndez, J. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.5456 · Cited by 35
Ou, H., Wu, H., Hung, H., Yang, Y., Wu, J., & Chang, C. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00419.2012 · Cited by 35
Metabolic Immunodepression and Metabolic Immunotherapy
Dilman, V. M., Berstein, L. M., Ostroumova, M. N., Fedorov, S. N., Poroshina, T. E., Tsyrlina, E. V., Buslaeva, V. P., Семиглазов, В. Ф., Ik, S., Bobrov, Y. F., et al. (2009) · Oncology · doi:10.1159/000225596 · Cited by 34
Intracerebroventricular Injection of Metformin Induces Anorexia in Rats
Lee, C. K., Choi, Y. J., Park, S., Kim, J. Y., Won, K. C., & Kim, Y. W. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.4.293 · Cited by 33
Contribution of Gluconeogenesis to Overall Glucose Output in Diabetic and Nondiabetic Men
Consoli, A., & Nurjhan, N. (1990) · Annals of Medicine · doi:10.3109/07853899009147268 · Cited by 32
Harman, E., Erten, Ç., Küçükzeybek, Y., Dırıcan, A., Er, H., & Oktay, T. M. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.10.5143 · Cited by 29
Alengrin, F., Grossi, G., Canivet, B., & Dolais-Kitabgi, J. (1987) · PubMed · Cited by 28
Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes.
Fanghänel, G., Silva, U., Sánchez‐Reyes, L., Sisson, D., Sotres, D. A., & Em, T. (1998) · PubMed · Cited by 26
Insulin glargine and cancer: another side to the story?
Gale, E. A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61477-x · Cited by 25
Depolarization of the liver cell membrane by metformin
Lutz, T. A., Estermann, A., Haag, S., & Scharrer, E. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00352-2 · Cited by 24
Metformin Does Not Adversely Affect Hormonal and Symptomatic Responses to Recurrent Hypoglycemia
Fruehwald‐Schultes, B., Kern, W., Oltmanns, K. M., Sopke, S., Toschek, B., Jan Born, A., Fehm, H. L., & Peters, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7790 · Cited by 23
Singh, S., Akhtar, N., & Ahmad, J. (2012) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.05.013 · Cited by 21
Transport of biguanides by human organic cation transporter OCT2
Sogame, Y., Kitamura, A., Yabuki, M., Komuro, S., & Takano, M. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.02.003 · Cited by 18
Metformin: a case of divide and conquer
Anastasiou, D. (2013) · Breast Cancer Research · doi:10.1186/bcr3387 · Cited by 8
Cited by
Chatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116
Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Metadata
- Authors
- Pernicova, I., & Korbonits, M.
- Venue
- Nature Reviews Endocrinology
- Published
- 2014-01-07
- Volume
- 10
- Issue
- 3
- Pages
- 143-156
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2148755064
- Cited by
- 1,349
- References
- 185
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.